# T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020

> **NCT01911065** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 54 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **BIOLOGICAL:** Zostavax™

## Key facts

- **NCT ID:** NCT01911065
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2023-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01911065

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01911065, "T Cell Responses to Varicella Zoster Virus (VZV) Vaccine SLVP020". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01911065. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*